From left to right: R&D General Manager Claude Bertrand, Ph.D., Senior Executive Vice-President R&D Emmanuel Canet,M.S., Ph.D., and President of Servier Olivier Laureau, presenting the 2018 LabCentral Golden Ticket, sponsored by Servier to Edward Holson, Ph.D., chief scientific officer of Amathus Therapeutics at LabCentral in Kendall Square, Cambridge, Massachusetts, on October 5, 2018. LabCentral is the premier shared laboratory workspace for high-potential life science startups in Greater Boston. Since LabCentral opened in late 2013, it has demonstrated that launching a company in its supportive ecosystem increases the probability of success: LabCentral startups can focus resources on meeting science & business milestones, with potential of 10-20x less capital investment than building out/operating their own dedicated wet lab/office facilities and its startups and graduates have raised more than $2.5 billion in VC and other funding.
From left to right: R&D General Manager Claude Bertrand, Ph.D., Senior Executive Vice-President R&D Emmanuel Canet,M.S., Ph.D., and President of Servier Olivier Laureau, presenting the 2018 LabCentral Golden Ticket, sponsored by Servier to Edward Holson, Ph.D., chief scientific officer of Amathus Therapeutics at LabCentral in Kendall Square, Cambridge, Massachusetts, on October 5, 2018. LabCentral is the premier shared laboratory workspace for high-potential life science startups in Greater Boston. Since LabCentral opened in late 2013, it has demonstrated that launching a company in its supportive ecosystem increases the probability of success: LabCentral startups can focus resources on meeting science & business milestones, with potential of 10-20x less capital investment than building out/operating their own dedicated wet lab/office facilities and its startups and graduates have raised more than $2.5 billion in VC and other funding.